Commentary: FDA statement on BPA’s safety is premature

Recommending policy using unpublished data that has not yet been peer reviewed is problematic.

Last week, the National Toxicology Program (NTP) released part of a multi-year study designed to resolve debate over the safety of BPA.

Keep reading... Show less
From our Newsroom

Above The Fold

Daily & Weekly newsletters all free.